Global Human Immunodeficiency Virus (HIV) Diagnosis Market Expected to Achieve 10.1% CAGR by 2029: Growth Forecast Insights

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Human Immunodeficiency Virus (HIV) Diagnosis Market Size By 2025?
The market encompassing human immunodeficiency virus (HIV) diagnostic solutions has seen considerable acceleration lately, projected to expand from a valuation of $4.2 billion in the year 2024 to reach $4.67 billion by 2025, reflecting an 11.2% compound annual growth rate (CAGR) over this period; this upswing throughout the past years is fundamentally linked to the increased accessibility of voluntary counseling and testing services, the advancement of sophisticated HIV antibody detection methods, the widespread impact of the HIV/AIDS pandemic, and the concerted efforts driven by community and peer support programs.

How Big Is the Human Immunodeficiency Virus (HIV) Diagnosis Market Size Expected to Grow by 2029?
Anticipated for swift expansion, the global market related to diagnosing human immunodeficiency virus (HIV) is projected to reach a valuation of $6.88 billion by 2029, fueled by an annual growth rate (CAGR) of 10.1%. This forward trajectory is largely supported by initiatives driving public health awareness, concentrated efforts toward ensuring fairness and broad access in healthcare, the integration of standardized testing within routine medical practices, the utilization of methods led by community members and peers, alongside an increasing prevalence of at-home testing options. Key developments shaping this market over the forecasted term encompass innovations in established testing methodologies, a strategic shift towards testing tailored for specific populations, increased testing provision through community outreach programs, ongoing emphasis on principle-based fairness and broad inclusion, and resource allocation decisions influenced by current policy directions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/human-immunodeficiency-virus-hiv-diagnosis-global-market-report

Which Key Market Drivers Powering Human Immunodeficiency Virus (HIV) Diagnosis Market Expansion and Growth?
Anticipated increases in blood donations are projected to be a key catalyst fueling the expansion of the market for HIV diagnosis in the foreseeable future. Blood contribution, which involves the voluntary process of drawing blood via phlebotomy-the insertion of a needle into a vein for collection-is expanding. This upward trend in blood giving is closely linked to progress in medical instrumentation, heightened societal involvement, and enhanced methods for attracting and keeping donors engaged. As the volume of donated blood increases, so too does the aggregate quantity of specimens accessible for the detection of HIV. This greater access to biological samples facilitates more thorough screening processes aimed at identifying HIV antibodies or antigens, thereby boosting both the precision and trustworthiness of diagnostic outcomes for HIV. As a concrete illustration, the United Kingdom's governmental body, NHS Blood and Transplant, reported a slight uptick in novel blood donors, moving from 119,016 across the 2022-2023 period to 119,371 during 2023-2024. Consequently, the surging rates of blood donations serve as a direct impetus propelling the HIV diagnosis market forward.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15587&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Human Immunodeficiency Virus (HIV) Diagnosis Market?
Leading firms within the HIV diagnostic sector are actively creating advanced chip-based real-time PCR testing methods specifically designed for HIV, aiming to achieve superior precision, quicker results, and broader availability. These sophisticated chip-based real-time PCR solutions for HIV function as diagnostic instruments, employing microfluidic chips or compact integrated circuits to execute real-time polymerase chain reaction (PCR) analysis for the identification of HIV. As an illustration, during August of 2022, Molbio Diagnostics, an Indian manufacturer specializing in molecular diagnostics, introduced the Truenat HIV-1 test, a chip-based real-time PCR assay intended for the precise quantification and diagnosis of human immunodeficiency virus type 1 (HIV-1) using both whole blood and plasma samples. This particular assay has been engineered to assist clinicians in monitoring the viral load of HIV-1 in individuals diagnosed with an HIV-1 infection. Fundamentally, the test employs Taqman chemistry, boasting exceptional sensitivity and specificity derived from its primers, necessitates a mere 6 mcL of sample, and incorporates an intelligent chip containing batch-specific information crucial for result quantification. Furthermore, the testing apparatus incorporates a chip re-use lockout mechanism and a reaction port engineered to effectively resist both contamination and sample evaporation.

What Are the Emerging Segments in the Human Immunodeficiency Virus (HIV) Diagnosis Market?
The human immunodeficiency virus (hiv) diagnosismarket covered in this report is segmented -

1) By Product: Consumables; Instruments; Software And Services
2) By Mode: Self-Test; Lab-Based
3) By End User: Diagnostic Laboratories; Hospitals; Research Institutions

Subsegments:
1) By Consumables: Test Kits (Rapid Hiv Test Kits, Elisa Test Kits); Reagents And Chemicals; Sample Collection Devices (Blood Collection Tubes, Lancets); Test Strips; Control And Calibration Kits; Disposable Gloves And Safety Equipment
2) By Instruments: Hiv Diagnostic Analyzers ( Automated Immunoassay Analyzers); Hiv Viral Load Testing Equipment; Cd4 Count Analyzers; Point-Of-Care Hiv Diagnostic Devices; Molecular Diagnostic Instruments ( Pcr Machines); Electrochemical And Optical Hiv Detection Instruments
3) By Software: Hiv Diagnosis Data Management Software; Electronic Health Record (Ehr) Integration Software; Hiv Test Result Interpretation Software; Laboratory Information Management Systems (Lims); Patient Monitoring And Tracking Software; Cloud-Based Hiv Diagnostic Reporting Tools
4) By Services: Diagnostic Testing Services; Hiv Testing Support Services ( Counseling, Education); Diagnostic Lab Services; Telemedicine And Remote Hiv Testing Services; Clinical Trial Services For Hiv Diagnostic Tests; Data Analytics And Interpretation Services For Hiv Testing

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15587&type=smp

Who Are the Global Leaders in the Human Immunodeficiency Virus (HIV) Diagnosis Market?
Major companies operating in the human immunodeficiency virus (HIV) diagnosis market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Becton dic*kinson and Company, Hologic Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Alere Inc., Cepheid Inc., OraSure Technologies Inc., Advanced Instruments Inc., BBI Solutions, Chembio Diagnostic Systems Inc., BioLytical Laboratories Inc., Avioq Inc., Advanced Biochemicals Ltd., Advanced Molecular Diagnostics, Atila BioSystems Inc., BioAssay Works LLC, Chemtron Biotech Inc.

Which are the Top Profitable Regional Markets for the Human Immunodeficiency Virus (HIV) Diagnosis Industry?
North America was the largest region in the HIV diagnosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human immunodeficiency virus (HIV) diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15587

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.